Altana officially opens Irish facility

16 July 2006

Altana Pharma, a division of the German Altana AG group, on July 7 performed the official opening of a new tablet production facility in Cork, Ireland, in the presence of the Irish Prime Minister, Bertie Ahern. The new plant will play an important role in Altana Pharma's global production network and provide extended capacity for the manufacturing of existing and future products, the firm said.

"The facility in Cork means that in addition to Oranienburg (Germany) Altana Pharma will have a second state-of-the-art, high-quality manufacturing site for solid formulations meeting the strictest international standards. This will provide greater flexibility and security in terms of supplying the market with our strategically important products," commented the firm's chief executive, Hans-Joachim Lohrisch.

The tablet manufacturing facility on the11-hectare plot in the Carrigtohill Industrial Park in Cork required an investment of 67.0 million euros ($85.8 million). As of July 7, the company employs 56 people. At full operational level some 150 employees will be able to produce three billion tablets a year.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight